Aurobindo Pharma Ltd Archives

Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals

Ali WaghbakriwalaApril 28, 2025April 28, 2025

by Ali WaghbakriwalaApril 28, 2025April 28, 202501573

Shares of Biocon, Zydus Lifesciences, and Aurobindo Pharma moved higher by up to 2% after the companies announced regulatory milestones achieved in the US and...

MARKETS

Aurobindo Pharma Shares Surge 4% as Arm Secures Final USFDA Approval

Ali WaghbakriwalaApril 23, 2025April 23, 2025

by Ali WaghbakriwalaApril 23, 2025April 23, 202501721

Share of Aurobindo Pharma Ltd surged 4% on 23 April after the company’s wholly-owned subsidiary announced securing final approval from the US Food and Drug...

BUSINESS

Aurobindo Pharma Gets USFDA Green Light for Generic Xarelto

Ali WaghbakriwalaApril 14, 2025April 14, 2025

by Ali WaghbakriwalaApril 14, 2025April 14, 202501233

Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, which is the...

BUSINESS

Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine

Ali WaghbakriwalaApril 10, 2025April 10, 2025

by Ali WaghbakriwalaApril 10, 2025April 10, 202501243

Pharmaceutical major Aurobindo Pharma Ltd, on 10 April, announced that its subsidiary, CuraTeQ Biologics, has successfully completed the phase 1 Trial of its new bone...

MARKETS

Aurobindo Pharma Falls 3% After US FDA Flags Issues at AP Facility

Dhruva KulkarniFebruary 19, 2025February 19, 2025

by Dhruva KulkarniFebruary 19, 2025February 19, 202501689

Shares of Aurobindo Pharma Ltd fell 3% after touching a day’s high of Rs 1,138.05 on 19th February, following the US FDA’s completion of a...

MARKETS

Aurobindo Pharma Shares Slump 2% Despite Telangana Secures VAI Status

Ali WaghbakriwalaJanuary 28, 2025January 28, 2025

by Ali WaghbakriwalaJanuary 28, 2025January 28, 202502375

Shares of Aurobindo Pharma Ltd slumped 2% on 28 January despite the company declaring that the Telangana active pharmaceutical ingredient (API) factory owned by one...

MARKETS

Aurobindo Pharma Shares Gain as Arm Secures Approval for Cancer Drug

Ali WaghbakriwalaDecember 23, 2024December 23, 2024

by Ali WaghbakriwalaDecember 23, 2024December 23, 202401443

Shares of Aurobindo Pharma Ltd were trading in the green and 1.8% higher on 23 December after the company’s step-down subsidiary, CuraTeQ Biologics s.r.o., announced...

MARKETS

Aurobindo Pharma Arm Receives USFDA Nod for Andhra Pradesh Facility; Shares Down 1%

Ali WaghbakriwalaSeptember 18, 2024September 18, 2024

by Ali WaghbakriwalaSeptember 18, 2024September 18, 20242 3866

Shares of Aurobindo Pharma Ltd. dropped 1% from a day’s high of Rs 1,559.90 on 18th September after the company announced that its step-down subsidiary,...

BUSINESS

Aurobindo Pharma Arm Gets USFDA Approval

Ali WaghbakriwalaSeptember 11, 2024September 11, 2024

by Ali WaghbakriwalaSeptember 11, 2024September 11, 202412701

Aurobindo Pharma Ltd on Wednesday 11 September announced that its new injectable facility in Andhra Pradesh has secured its first product approval from the US...

MARKETS

Aurobindo Pharma Shares Drop 6% after Eugia unit-III receives USFDA warning letter

Ali WaghbakriwalaAugust 16, 2024August 16, 2024

by Ali WaghbakriwalaAugust 16, 2024August 16, 20243 1794

Shares of Aurobindo Pharma Ltd. dropped 6% after touching a day’s high of Rs 1,527 on 16th August, following the company’s disclosure that its Eugia...

EquityPandit

Tag : Aurobindo Pharma Ltd

Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals

Aurobindo Pharma Shares Surge 4% as Arm Secures Final USFDA Approval

Aurobindo Pharma Gets USFDA Green Light for Generic Xarelto

Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine

Aurobindo Pharma Falls 3% After US FDA Flags Issues at AP Facility

Aurobindo Pharma Shares Slump 2% Despite Telangana Secures VAI Status

Aurobindo Pharma Shares Gain as Arm Secures Approval for Cancer Drug

Aurobindo Pharma Arm Receives USFDA Nod for Andhra Pradesh Facility; Shares Down 1%

Aurobindo Pharma Arm Gets USFDA Approval

Aurobindo Pharma Shares Drop 6% after Eugia unit-III receives USFDA warning letter

EquityPandit